Acorah Software Products - Accounts Production 16.8.200 false true 31 March 2024 1 April 2023 false 1 April 2024 31 March 2025 31 March 2025 08474661 E Mughal F Zaffar iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 08474661 2024-03-31 08474661 2025-03-31 08474661 2024-04-01 2025-03-31 08474661 frs-core:CurrentFinancialInstruments 2025-03-31 08474661 frs-core:ComputerEquipment 2025-03-31 08474661 frs-core:ComputerEquipment 2024-04-01 2025-03-31 08474661 frs-core:ComputerEquipment 2024-03-31 08474661 frs-core:ShareCapital 2025-03-31 08474661 frs-core:RetainedEarningsAccumulatedLosses 2025-03-31 08474661 frs-bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 08474661 frs-bus:FilletedAccounts 2024-04-01 2025-03-31 08474661 frs-bus:SmallEntities 2024-04-01 2025-03-31 08474661 frs-bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 08474661 frs-bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 08474661 frs-bus:Director1 2024-04-01 2025-03-31 08474661 frs-bus:Director1 2024-03-31 08474661 frs-bus:Director1 2025-03-31 08474661 frs-bus:CompanySecretary1 2024-04-01 2025-03-31 08474661 frs-countries:EnglandWales 2024-04-01 2025-03-31 08474661 2023-03-31 08474661 2024-03-31 08474661 2023-04-01 2024-03-31 08474661 frs-core:CurrentFinancialInstruments 2024-03-31 08474661 frs-core:ShareCapital 2024-03-31 08474661 frs-core:RetainedEarningsAccumulatedLosses 2024-03-31
Registered number: 08474661
Kneecare Ltd
Financial Statements
For The Year Ended 31 March 2025
Contents
Page
Balance Sheet 1
Notes to the Financial Statements 2—3
Page 1
Balance Sheet
Registered number: 08474661
2025 2024
Notes £ £ £ £
FIXED ASSETS
Tangible Assets 4 89 417
89 417
CURRENT ASSETS
Debtors 5 4,755 5,940
Cash at bank and in hand 101,639 93,801
106,394 99,741
Creditors: Amounts Falling Due Within One Year 6 (7,385 ) (3,581 )
NET CURRENT ASSETS (LIABILITIES) 99,009 96,160
TOTAL ASSETS LESS CURRENT LIABILITIES 99,098 96,577
NET ASSETS 99,098 96,577
CAPITAL AND RESERVES
Called up share capital 7 100 100
Profit and Loss Account 98,998 96,477
SHAREHOLDERS' FUNDS 99,098 96,577
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
E Mughal
Director
26th December 2025
The notes on pages 2 to 3 form part of these financial statements.
Page 1
Page 2
Notes to the Financial Statements
1. General Information
Kneecare Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 08474661 . The registered office is 15 Russell Road, Birmingham, B13 8RA.
The presentation currency of the financial statements is the Pound Sterling (£).
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
The turnover shown in the profit and loss account represents amounts invoiced during the year.
2.3. Tangible Fixed Assets and Depreciation
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value
of each asset over its estimated useful life.
Office Equipment 20% on cost
2.4. Leasing and Hire Purchase Contracts
Rentals applicable to operating leases where substantially all of the benefits and risks of ownership remain with the lessor are charged to profit and loss account as incurred.
2.5. Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.
Current or deferred taxation assets and liabilities are not discounted.
Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.
2.5. Deferred Tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.
Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 2 (2024: 2)
2 2
Page 2
Page 3
4. Tangible Assets
Office Equipment
£
Cost
As at 1 April 2024 1,642
As at 31 March 2025 1,642
Depreciation
As at 1 April 2024 1,225
Provided during the period 328
As at 31 March 2025 1,553
Net Book Value
As at 31 March 2025 89
As at 1 April 2024 417
5. Debtors
2025 2024
£ £
Due within one year
Other debtors 4,755 5,940
6. Creditors: Amounts Falling Due Within One Year
2025 2024
£ £
Other creditors 3,339 3,303
Taxation and social security 4,046 278
7,385 3,581
7. Share Capital
2025 2024
£ £
Allotted, Called up and fully paid 100 100
8. Directors Advances, Credits and Guarantees
The following advances and credits to directors subsisted during the current and prior periods:
As at 1 April 2024 Amounts advanced Amounts repaid Amounts written off As at 31 March 2025
£ £ £ £ £
Dr Ejaz Mughal (33 ) 16,895 (16,874 ) - (12 )
The above loan is unsecured, interest free and repayable on demand.
Page 3